Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration

被引：10

作者：

Caraffini, Veronica ^{[1
]}

Perfler, Bianca ^{[1
]}

Berg, Johannes Lorenz ^{[1
]}

Uhl, Barbara ^{[1
]}

Schauer, Silvia ^{[2
]}

Kashofer, Karl ^{[2
]}

Ghaffari-Tabrizi-Wizsy, Nassim ^{[3
]}

Strobl, Herbert ^{[3
]}

Woelfler, Albert ^{[1
]}

Hoefler, Gerald ^{[2
]}

Sill, Heinz ^{[1
]}

Zebisch, Armin ^{[1
]}

机构：

[1] Med Univ Graz, Div Hematol, Auenbruggerpl 38, A-8036 Graz, Austria

[2] Med Univ Graz, Inst Pathol, Graz, Austria

[3] Med Univ Graz, Inst Pathophysiol & Immunol, Graz, Austria

来源：

BLOOD | 2018年 / 131卷 / 07期

基金：

奥地利科学基金会;

关键词：

KINASE INHIBITOR PROTEIN; WORLD-HEALTH-ORGANIZATION; EXPRESSION; MUTATIONS; CLASSIFICATION; NEOPLASMS; REVISION; CANCER;

D O I：

10.1182/blood-2017-09-804906

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：826 / 830

页数：7

共 25 条

[1] RKIP: Much more than Raf Kinase inhibitory protein [J].

Al-Mulla, Fahd ;

Bitar, Milad S. ;

Taqi, Zainab ;

Yeung, Kam C. .

JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) :1688-1702

[2] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert ;

Thiele, Jurgen ;

Borowitz, Michael J. ;

Le Beau, Michelle M. ;

Bloomfield, Clara D. ;

Cazzola, Mario ;

Vardiman, James W. .

BLOOD, 2016, 127 (20) :2391-2405

[3] How I treat extramedullary acute myeloid leukemia [J].

Bakst, Richard L. ;

Tallman, Martin S. ;

Douer, Dan ;

Yahalom, Joachim .

BLOOD, 2011, 118 (14) :3785-3793

[4] Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome [J].

Chang, H ;

Brandwein, J ;

Yi, QL ;

Chun, K ;

Patterson, B ;

Brien, B .

LEUKEMIA RESEARCH, 2004, 28 (10) :1007-1011

[5] Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome [J].

Chatterjee, Devasis ;

Sabo, Edmond ;

Tavares, Rosemarie ;

Resnick, Murray B. .

CLINICAL CANCER RESEARCH, 2008, 14 (10) :2994-3001

[6] Raf Kinase Inhibitor Protein (RKIP) Deficiency Decreases Latency of Tumorigenesis and Increases Metastasis in a Murine Genetic Model of Prostate Cancer [J].

Escara-Wilke, June ;

Keller, Jill M. ;

Ignatoski, Kathleen M. Woods ;

Dai, Jinlu ;

Shelley, Gregory ;

Mizokami, Atsushi ;

Zhang, Jian ;

Yeung, Miranda L. ;

Yeung, Kam C. ;

Keller, Evan T. .

PROSTATE, 2015, 75 (03) :292-302

[7] Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008 [J].

Ganzel, Chezi ;

Manola, Judith ;

Douer, Dan ;

Rowe, Jacob M. ;

Fernandez, Hugo F. ;

Paietta, Elisabeth M. ;

Litzow, Mark R. ;

Lee, Ju-Whei ;

Luger, Selina M. ;

Lazarus, Hillard M. ;

Cripe, Larry D. ;

Tallman, Martin S. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (29) :3544-+

[8] Evidence for a role of decitabine in the treatment of myeloid sarcoma [J].

Gornicec, Max ;

Woelfler, Albert ;

Stanzel, Susanne ;

Sill, Heinz ;

Zebisch, Armin .

ANNALS OF HEMATOLOGY, 2017, 96 (03) :505-506

[9] Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP [J].

Hatzl, Stefan ;

Geiger, Olivia ;

Kuepper, Maja Kim ;

Caraffini, Veronica ;

Seime, Till ;

Furlan, Tobias ;

Nussbaumer, Erika ;

Wieser, Rotraud ;

Pichler, Martin ;

Scheideler, Marcel ;

Nowek, Katarzyna ;

Jongen-Lavrencic, Mojca ;

Quehenberger, Franz ;

Woelfler, Albert ;

Troppmair, Jakob ;

Sill, Heinz ;

Zebisch, Armin .

CANCER RESEARCH, 2016, 76 (12) :3644-3654

[10] Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing [J].

Kashofer, Karl ;

Gornicec, Max ;

Lind, Karin ;

Caraffini, Veronica ;

Schauer, Silvia ;

Beham-Schmid, Christine ;

Woelfler, Albert ;

Hoefler, Gerald ;

Sill, Heinz ;

Zebisch, Armin .

LEUKEMIA & LYMPHOMA, 2018, 59 (02) :501-504

← 1 2 3 →